{"id":212437,"name":"TOBACCO 21","slug":"tobacco-21","state":"OH","country":"United States of America","description":"Foundation to reduce health and economic impact of tobacco use/addiction.","totalSpending":330000,"filings":19,"yearlySpending":[{"year":2021,"income":20000},{"year":2022,"income":80000},{"year":2023,"income":80000},{"year":2024,"income":80000},{"year":2025,"income":70000}],"issues":[{"code":"TOB","display":"Tobacco"},{"code":"CSP","display":"Consumer Issues/Safety/Products"},{"code":"HCR","display":"Health Issues"},{"code":"BUD","display":"Budget/Appropriations"}],"firms":["MCALLISTER & QUINN, LLC"],"lobbyists":["ANDREW QUINN","KENDRICK MASTERMAN-BURNS","ELIZABETH FOLEY","JASON HOIS","MATTHEW LAMY","BRANDON REA"],"govEntities":["HOUSE OF REPRESENTATIVES","SENATE","Food & Drug Administration (FDA)","Health & Human Services, Dept of (HHS)"],"sampleDescriptions":["Lobbying issues related to FDA tobacco sales compliance.","No Bill #: Issues related to FDA tobacco sales compliance.","No Bill: Issues related to FDA tobacco sales compliance. Opposition to new FDA commissioner.","No Bill: Issues related to FDA tobacco sales compliance. Opposition to new FDA commissioner.","No Bill: Issues related to FDA tobacco sales compliance. Opposition to new FDA commissioner."]}